WHO approves Sinovac COVID-19 vaccine, 2nd Chinese-made dose listed

Middle East
01-06-2021 | 10:54
High views
Share
LBCI
Share
LBCI
Whatsapp
facebook
Twitter
Messenger
telegram
telegram
print
WHO approves Sinovac COVID-19 vaccine, 2nd Chinese-made dose listed
Whatsapp
facebook
Twitter
Messenger
telegram
telegram
print
0min
WHO approves Sinovac COVID-19 vaccine, 2nd Chinese-made dose listed
The World Health Organization (WHO) has approved a COVID-19 vaccine made by Sinovac Biotech for emergency use listing, the second Chinese-produced shot to get its endorsement, a WHO statement said on Tuesday.

WHO emergency listing is a signal to national regulators on a product's safety and efficacy. It would also allow the shot to be included in COVAX, the global program to provide vaccines mainly for poor countries, which currently faces major supply problems due to India's suspension of vaccine exports.

In a statement, the independent panel of experts said it recommended Sinovac's vaccine for adults over 18, with a second dose 2-4 weeks later. There was no upper age limit as data suggested it is likely to have a protective effect in older people.




REUTERS

Breaking Headlines

WHO

Sinovac

Vaccine

Covid-19

Download now the LBCI mobile app
To see the latest news, the latest daily programs in Lebanon and the world
Google Play
App Store
We use
cookies
We use cookies to make
your experience on this
website better.
Accept
Learn More